NCT02305381 · Interventional trial
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes
Overall registry status Completed
Phase 3
Conditions Diabetes, Diabetes Mellitus, Type 2
Delaware Valley sites
- Novo Nordisk Investigational Site · Levittown, PA · Bucks County
- Novo Nordisk Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory